Advance Agrolife Limited — PPTs, 06-08-2026: Investor Presentation

Here's a retail-investor-friendly summary of Advance Agrolife Limited's investor presentation:

**Business Performance:**

Advance Agrolife reported its best-ever quarterly performance in Q1 FY2027, with revenue soaring 96% year-over-year to ¥3304 million. This strong growth was driven by robust demand and effective inventory management. EBITDA also saw a significant jump of 105% YoY to ¥351 million, with PAT increasing by an impressive 152% YoY to ¥225.5 million.

**Growth Drivers or Strategy:**

The company is focused on expanding its manufacturing capabilities through new facilities (Unit-4 by Q3 FY27 and Unit-5 in Gujarat). A key strategy is backward integration into technical manufacturing to capture full molecule margins, reducing COGS by 25-30% for certain products. They are also pushing to increase export revenue share from 2% to 20% by FY29.

**Recent Developments:**

Construction has begun on Unit-5 in Dahej, Gujarat, a technical grade pesticide manufacturing facility. They are also expanding their 2,4-D capacity by 4x to 10,000 MT, with potential relocation to Dahej for raw material cost benefits.

**Key Financial Metrics:**

* **Revenue:** ¥3304 million (up 96% YoY)

* **EBITDA:** ¥351 million (up 105% YoY)

* **PAT:** ¥225.5 million (up 152% YoY)

**Management Commentary / Outlook:**

Management is optimistic about the rest of FY2027, citing a strong operational foundation and clear growth strategies. They highlighted their ability to meet rising market demand due to adequate inventory and strengthened working capital. The focus remains on volume growth, backward integration for margin expansion, and export diversification.